This page was downloaded with the free trial version of Inspyder Web2Disk.
To remove this message, please purchase the full version from our website.
Inspyder Website

NUHT logo

IV to PO Switch Guideline

N.B. as with all standard antibiotic guidelines on this website, paediatric patients and adult patients with chemotherapy-related neutropenia and/or bone marrow transplant patients are excluded.

 

  • The majority of patients with a severe infection who are adequately absorbing oral medication and initially require IV therapy can be safely switched to oral therapy within 48 hours with a number of benefits.

  • Considerations for the early switch to oral therapy "COMS". Patients should generally have all of the COMS criteria.

  • Review at 24-48 hours after starting IVs and then daily

 

C

Clinical improvement observed

O

Oral route is not compromised vomiting, malabsorptive disorder, NBM, swallowing problems, unconscious, severe diarrhoea)

Suitable oral antibiotic option available (click here for recommended oral switches) 

NB: if NG/PEG feeding then please consult your pharmacist

M

Markers showing a trend towards normal:

Patient should be apyrexial for the last 24 hours (Temp>36oC and <38oC) AND no more than one of the following,

  • Heart rate >90/min,
  • Respiratory rate >20/min,
  • BP unstable,
  • WCC <4 or>12 White cell count should show a trend towards normal; absence of such should not impede the switch if all other criteria are met and not neutropaenic.

S

Specific indication/deep-seated infection

Certain multi-resistant organisms often require treatment with agents that are only available in an intravenous form, please seek microbiology advice regarding the length of treatment.

 

Caution; the antibiotic doses recommended on this website are intended for adult patients with normal renal and liver function unless otherwise stated. Dosing advice for patients with renal impairment is available here.

Read our copyright and disclaimer statement